Ads by Google
Nexavar becomes the first FDA-approved drug treatment therapy for patients suffering from liver cancer. Nexavar is made by Bayer Healthcare and the FDA liver cancer treatment node was announced today.
Progen Pharmaceuticals awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence the Phase 3 program as rapidly as possible, the Company will no longer continue with the Special Protocol Assessment process.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may "spontaneously" cause liver cancer.
Bayer and Onyx Pharmaceuticals say Nexavar tablets significantly extended overall survival in primary liver cancer versus those taking placebo by 44 percent.
Trial of Nexavar for liver cancer survival and treatment to be stopped early based on positive outcome.
Despite liver cancer being extremely rare, with only around ten cases recorded annually in the UK, the finding is significant as the disease should be preventable once the gene fault is identified.
Liver Cancer Risk
Researchers have announced that they have discovered a possible way to identify children at risk of liver cancer.
Researchers at King's College Hospital and King's College London found that all the children they studied who went on to develop liver cancer shared a common genetic flaw.
Colchicine, an anti inflammatory drug most often used to treat gout, prevented liver cancer in patients with hepatitis virus related end stage liver disease.
A unique pattern of activity for genes in cells located in the tissue surrounding a liver tumor can accurately predict whether the cancer will spread to other parts of the liver or to other parts of the body.
liver cancer is likely caused by cycles of liver cell death and renewal.
Omega 3 fatty acids may be an effective therapy for both the treatment and prevention of human liver cancers.
Cirrhosis patients with small nodules in their livers are 25 times more likely to develop cancer than those without nodules, a study conducted at UNC Hospitals has concluded.
Shaped beam radiation therapy is a promising treatment for life threatening metastatic liver tumors.
By custom modifying a device called a mass spectrometer a team has found that the wand-like sample probe can be used to identify liver cancers.
Liver cancer is often not diagnosed till advanced stages because the symptoms are difficult to recognize. Some signs of liver cancer are pain, jaundice and unexplained weight loss.
It's the first study testing a marker for liver cancer, and the first Phase II EDRN supported study.